A Study Evaluating Soticlestat in Participants With Dravet Syndrome or Lennox-Gastaut Syndrome Who Have Been Exposed to Fenfluramine

Clinical trial NCT06422377 · TERMINATED

Trial details

NCT number: NCT06422377
Sponsor: Takeda
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Dravet Syndrome (DS)Lennox-Gastaut Syndrome (LGS)

Start date: 2024-04-25
Primary completion: 2024-08-14
Enrollment: 1

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.